IMPACT OF THE 2017 GOLD STRATEGY ON TIOTROPIUM plus OLODATEROL RESPONSE

被引：0
|
作者：
Langton, D. [1 ,2 ]
Ferguson, G. [3 ]
Voss, F. [4 ]
Maltais, F. [5 ]
Groenke, L. [4 ]
Buhl, R. [6 ]
Watz, H. [7 ]
机构：
[1] Frankston Hosp, Thorac Med, Frankston, Vic, Australia
[2] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia
[3] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[4] Boehringer Ingelheim Corp, Ingelheim, Germany
[5] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
[6] Johannes Gutenberg Univ Mainz, Mainz, Germany
[7] LungClin Grosshansdorf Pulm Res, Pulm Res Inst, Grosshansdorf, Germany
来源：
RESPIROLOGY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TO 129
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [21] POOLED SAFETY ANALYSIS OF ADJUDICATED SERIOUS ADVERSE EVENTS WITH THE COMBINATION OF TIOTROPIUM plus OLODATEROL
    Buhl, R.
    Tetzlaff, K.
    Korducki, L.
    Vogelmeier, C.
    McGarvey, L.
    THORAX, 2015, 70 : A140 - A140
  • [22] Characteristics of Patients With and Without COPD Exacerbations During the Tiotropium plus Olodaterol TONADO Studies
    Abrahams, Roger
    Bjermer, Leif
    Ferguson, Gary
    Pizzichini, Emilio
    Voss, Florian
    Tafur, Carlos
    Buhl, Roland
    CHEST, 2016, 150 (04) : 858A - 858A
  • [23] Lung Function Response With Tiotropium plus Olodaterol Maintenance Treatment in Patients With COPD in the TONADO and OTEMTO Studies: A Subgroup Analysis by Age
    Ferguson, Gary
    Clerisme-Beaty, Emmanuelle
    Groenke, Lars
    Voss, Florian
    Karpel, Jill
    CHEST, 2015, 148 (04)
  • [24] Tiotropium/Olodaterol Versus Tiotropium in the Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease: Impact of Adjusting for Baseline Characteristics
    Jenkins, C.
    Calverley, P. M.
    Carter, K.
    Tetzlaff, K.
    de la Hoz, A.
    Anzueto, A.
    Rabe, K. F.
    Wedzicha, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [25] COST-EFFECTIVENESS OF THE FIXED-DOSE COMBINATION TIOTROPIUM plus OLODATEROL VERSUS TIOTROPIUM BASED ON THE DYNAGITO TRIAL RESULTS IN FRANCE
    Luciani, L.
    Hoogendoorn, M.
    Ramos, Corro, I
    Baldwin, M.
    Le Lay, K.
    Detournay, B.
    Fabron, C.
    Rutten-van Molken, M. P.
    VALUE IN HEALTH, 2018, 21 : S412 - S412
  • [26] COST-EFFECTIVENESS OF THE FIXED-DOSE COMBINATION TIOTROPIUM plus OLODATEROL VERSUS TIOTROPIUM AND LABA/ICS IN FINLAND, SWEDEN AND THE NETHERLANDS
    Hoogendoorn, M.
    Ramos, Corro, I
    Soulard, S.
    Cook, J.
    Soini, E.
    Fast, T.
    Rutten-van Molken, M.
    VALUE IN HEALTH, 2020, 23 : S722 - S722
  • [27] TIOROPIUM plus OLODATEROL RESPIMAT; BUDGET IMPACT IN THE UK
    Ternouth, A.
    Tebboth, A.
    Selya-Hammer, C.
    Guix, Gonzalez-Rojas N.
    VALUE IN HEALTH, 2015, 18 (07) : A496 - A497
  • [28] LUNG FUNCTION WITH TIOTROPIUM PLUS OLODATEROL IN EAST ASIAN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Buhl, Roland
    Joens, Olaf
    Zhao, Yihua
    Ichinose, Masakazu
    RESPIROLOGY, 2015, 20 : 51 - 51
  • [29] ANALYSIS OF THE EFFICACY AND SAFETY OF THE COMBINATION OF TIOTROPIUM plus OLODATEROL IN PATIENTS WITH COPD BY PREVIOUS USAGE OF INHALED CORTICOSTEROIDS
    Korn, S.
    Buhl, R.
    Groenke, L.
    Korducki, L.
    Amato, V. C.
    Ferguson, G. T.
    Abrahams, R.
    THORAX, 2015, 70 : A37 - A37
  • [30] Effects of acute dual bronchodilator treatment (tiotropium plus olodaterol) on cardiopulmonary interactions in hyperinflated patients with COPD
    Berton, Danilo Cortozi
    Marques, Renata Diniz
    Palmer, Brandon
    Webb, Katherine
    O'Donnell, Denis E.
    Neder, J. Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
12345